The Neurotechnology Industry 2012 Report

Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets

Now in its eighth year, The Neurotechnology Industry 2012 Report is an expanded and updated 580 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 18 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, traumatic brain injury and stroke.

Report Highlights

The Neurotechnology Industry 2012 Report provides a unified market-based framework to help executives, investors, and governments easily identify opportunities, understand the competitive landscape and visualize the dynamics of these rapidly growing markets.

- More than 500 profiles of public and private neurotech companies including drugs, devices and diagnostics
- Pipelines and market analysis for 18 brain and nervous system illnesses including: addiction, Alzheimer's disease, anxiety, attention disorders, depression, epilepsy, hearing loss, insomnia, mild cognitive impairment, migraine, multiple sclerosis, obesity, pain, Parkinson's disease, retinal disorders, schizophrenia, stroke, and traumatic brain injury
- Top neurotech investors, venture capital firms, and venture capital trends (1999-Q12012)
- Neurotech IPOs (2004-Q12012), M&A (2004-Q12012), Partnering and Licensing deals (2005-Q12012) and public neurotech stock performance
- Analysis of biological basis, current treatment options, and emerging therapeutic strategies
- Analysis of compounds, cell therapies and devices in clinical trials (and abandoned) by company, mechanism of action and stage of development for each indication
- Global and US market size, worldwide revenues for each indication
- Extensive discussion of specific technological, demographic, regulatory and intellectual property trends SHOW LESS READ MORE >

1: Executive Summary

The Brain Industry Revealed
Neuropharmaceuticals
Cell Therapies
Neurodevices
Neurodiagnostics
Investment Risks and Opportunities
Translating Neuroscience into Neurotech
The Neurotech Market Opportunity
Key Industry Facts and Findings

2: Trends and Drivers

Converging Technology Drivers
Crossing the Blood Brain Barrier
Demographic Drivers
More People Living Longer
Social Drivers
The Lifestyle Improvement Market
Economic Drivers
Global Economic Burden of Brain-Related Illness
Rising Health Care Costs
Research Funding
US Government Research Funding
Stem Cell Funding
International Government Research Funding
Foundations Focus on the Brain
Intellectual Property Trends
Global Intellectual Property Protection
Patent Expirations
Neurotech Merger and Acquisition Activity (2005-Q12012)

3: Neuropharmaceutical Sector

Neuropharmaceutical Sector Overview
Trends in Neuropharmaceuticals
Big Pharma Scales Back
Treatments in Development and Abandoned by Indication 2006-2012
Neuropharmaceutical Partnering and Licensing
Partnering and Licensing Personnel
Partnering and Licensing Deals 2004-Q12012
Neurology Markets and Pipelines
Alzheimer's Disease (AD)
AAMI and MCI
Epilepsy and Seizure Disorders
Huntington's disease
Migraine
Multiple Sclerosis
Parkinson's Disease
Sleep Disorders
Restless Legs Syndrome
Stroke
Traumatic Brain Injury
Psychiatry Markets and Pipelines
Addiction
Anxiety Disorders
Attention Disorders
Depressive Disorders
Bipolar Disorder
Obesity
Schizophrenia
Cognitive Impairment Associated with Schizophrenia
Sensory Markets and Pipelines
Pain
Retinal Disorders

4: Stem Cells and Neuroregeneration

Defining Stem Cell Markets and Players
Therapeutics
Drug Discovery Tools
Stem Cell Banking
Stem Cell Approaches
Background
The Science of Transplantion
Controlling Immune Rejection and Infection
Sources and Harvesting of Stem Cells
Embronic Stem Cells
Fetal Stem Cells
Adult Stem Cells
Stimulation of Endogenous Stem Cells
Stem Cells Scientific Hurdles
Markets and Treatments in Development
Alzheimer's Disease
Amyotrophic Lateral Sclerosis (ALS)
Hearing Loss
Huntington's Disease (HD)
Multiple Sclerosis (MS)
Parkinson's Disease
Retinal Disorders
Spinal Cord Injury (SCI)
Stroke
Other CNS Diseases

5: Neurodevice Sector

Neurodevice Sector Overview
Neurodevice Markets
Regulatory Process in the US
Regulatory Process in the EU
Neurodevice Sector Trends
Investment by Major Device companies
Neurodevice M&A Activity (2005-Q12012)
Neuroprosthetic Devices
Cochlear Implants
Retinal Implants
Motor Prostheses and Brain Computer Interfaces
Neuromodulation Devices
Neuromodulation Device Clinial Trials and Recent Approvals
Deep Brain Stimulation
Essential Tremor
Parkinson's Disease
Primary Dystonia
Severe Obsessive Compulsive Disorder
Treatment-Resistant Depression
Epilepsy
Traumatic Brain Injury and Stroke
Transcranial Magnetic Stimulation (TMS)
Alzheimer's
Treatment Resistant Depression
Migraine
Spinal Cord Stimulation (SCS)
Chronic and Neuropathic Pain
Spinal Cord Injury
Vagus Nerve Stimulation (VNS)
Epilepsy
Treatment-Resistant Depression
Obesity
Peripheral Stimulation
Assisted Breathing
Epilepsy
Fecal Incontinence
Foot Drop
Hypertension
Migraine
Neuropathic Pain
Restless Legs Syndrome
Sleep Apnea
Stroke
Urinary Conditions
Gastric Modulation and Obesity
Neurosurgical devices
Radiosurgical Devices
Neurosurgical Navigation and Equipment
Image Guided Navigation (IGN)
Intraoperative Magnetic Resonance Imaging (iMRI)
Automated Surgical Systems
Brain Monitoring
Temperature Control Systems
Neurovascular Intervention
Ischemic Stroke
Catheters, Stents and Perfusion devices
Retrieval and Protection devices
Ultrasound Thrombolysis
Hemorrhagic Stroke
Coils
Liquid Embolics
Stents
Neurosoftware
Attention Deficit Disorder
Cognition and Aging
Stress and Emotional Wellbeing
Autism
Addiction and Obesity
Pain
Schizophrenia

6: Neurodiagnostics Sector

Neurodiagnostic Sector Overview
FDA Approval and Reimbursement of Diagnostics
Neuroimaging Technologies
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Nuclear Medicine Imaging (PET, SPECT)
Electro-encephalography (EEG)
Magneto-encephalography (MEG)
In Vitro Diagnostics
In Vitro Diagnostics Regulatory Landscape
Emerging Diagnostics for Alzheimer's Disease
Emerging Diagnostics for TBI
Genetic Testing and Pharmacogenomics
Protein Biomarker Assays
Pattern Recognition in Diagnostics
Emerging Diagnostics for Psychiatry
Emerging Diagnostics for Autism
Neuroinformatics
Diagnostic Software

7: Private Neurotechnology Investment

Private Investment in Neurotechnology
Venture Capital Investment Trends
Neurotech Venture Capital Investment
Investing in Neuropharmaceuticals
Investing in Stem Cells and Neuroregeneration
Investing in Neurodevices
Investing in Neurodiagnostics
Private Company Financings, 2011
Top financings 2004-2011
Leading Neurotech Investors
Leading Venture Capital Firms

8: Public Neurotechnology Investment

Investing in Public Neurotech Companies
Neurotech Stock Universe
Neurotech Initial Public Offerings
NASDAQ NeuroInsights Neurotech Index

9: Neurotechnology Research Centers

Leading Neurotechnology Research Centers
University of California, San Francisco (UCSF)
University of California, Los Angeles (UCLA)
University of California, San Diego (UCSD)
Harvard
Stanford University
Massachusetts Institute of Technology (MIT)
Columbia University
Washington University, St. Louis
University College London (UCL)
Karolinska Institutet, Stockholm
RIKEN Brain Science Institute, Japan
Places to Watch
National Brain Research Centre (NBRC), India
Neurosciences Victoria, Australia (NSV)
Univeristy of Helsinki, Finland

10: Leading Neurotechnology Regions

The Global Neurotech Economy
Nexus Ranking and Methodology
Established Neurotech Nexus'
Emerging Neurotech Nexus'
Nascent Neurotech Nexus'
Conclusions and Policy Recommendations

11: Company Profiles

Neuropharmaceutical & Cell Therapy Companies: Private
Neuropharmaceutical & Cell Therapy Companies: Public
Neurodevice Companies: Private
Neurodevice Companies: Public
Neurodiagnostic Companies: Private
Neurodiagnostic Companies: Public

12: Index

The Neurotechnology Industry 2012 Report: Exhibits, Tables, and Charts

1-1: Number of Individuals Afflicted by Indication, US and Worldwide, Top 15 Indications
1-2: Global Pharmaceutical Sales by Indication, 2011
1-3: Neurotechnology Industry Taxonomy
1-4: Proportion of Patient Population Segmented by Neurotech Market Opportunity
1-5: NASDAQ NeuroInsights Neurotech Index Performance vs. S&P500, NASQAQ Composite, and NASDAQ Biotechnology Index

2-1: Projected Percentage Increase in Global Populations aged 65 and over, 1994-2020
2-2: Neuropharmaceutical Patent Expirations and Generic Competition, 2003-2020
2-3: Selected US Foundations with a Significant focus on Brain Research and Education
2-4: Most Generous Philanthropists for Medical and Brain Research
2-5: Neurotech M&A Activity (2004-Q12012)

3-1: Neuropharmaceutical Revenues, Growth Rate by Indication (2011)
3-2: FDA Pharmaceutical Approval Process
3-3: Products Abandoned and Approved by Indications (2006-2012)
3-4: Neuropharmaceutical Partnering and Licensing Deals (2004-Q1 2012)
3-5: WW Revenue of Top Alzheimer's Drugs (2006-2011)
3-6 Clinical Trials for Alzheimer's disease (company, compound, phase, mechanism)
3-7: Clinical Trials for AAMI and MCI (company, compound, phase, mechanism)
3-8: WW Revenue of Top Antiepileptics (2006-2011)
3-9: Clinical Trials for Epilepsy (company, compound, phase, mechanism)
3-10: Clinical Trials for Huntington's disease (company, compound, phase, mechanism)
3-11: WW Revenue of Top Migraine Agents(2006-2011)
3-12: Clinical Trials for Migraine (company, compound, phase, mechanism)
3-13: Clinical Trials for Multiple sclerosis (company, compound, phase, mechanism)
3-14: WW Revenue of Top Anti-Parkinson's Agents (2006-2011)
3-15: Clinical Trials for Parkinson's disease (company, compound, phase, mechanism)
3-16: Clinical Trials for sleep disorders (company, compound, phase, mechanism)
3-17: Clinical Trials for stroke Treatment (company, compound, phase, mechanism)
3-18: Clinical Trials for Traumatic Brian Injury (company, compound, phase, mechanism)
3-19: Number of People with Addiction and Impulse Control Disorders (WW and US)
3-20: Clinical Trials for Addition and Substance abuse (company, compound, phase, mechanism)
3-21: Clinical Trials for Snxiety Disorders (company, compound, phase, mechanism)
3-22: WW Revenue of Top ADHD Drugs (2006-2011)
3-23: Clinical Trials for ADHD (company, compound, phase, mechanism)
3-24: WW Revenue of Top Antidepressants (2006-2011)
3-25: Clinical Trials for Depressive disorders (company, compound, phase, mechanism)
3-26: Clinical Trials for Obesity Treatment (company, compound, phase, mechanism)
3-27: Clinical Trials for Schizophrenia and Psychosis (company, compound, phase, mechanism)
3-28: WW Revenue of Top Antipsychotics (2006-2011)
3-29: Clinical Trials for Retinal disorders (company, compound, phase, mechanism)
3-30: Clinical Trials for Nociceptive Pain (company, compound, phase, mechanism)
3-31: Clinical Trials for Neuropathic Pain (company, compound, phase, mechanism)

4-1: Neurodevice Markets and Revenues (Neuroprosthetic, Neuromodulation, Neurosurgical, Neurofeedback)
4-2: Neurodevice Investment Activity: Medtronic, Boston Scientific, J&J
4-3: Neurodevice M&A Activity (2004-Q12012)
4-4: Neuromodulation Device Clinical Trials

5-1: Neurodiagnostics Markets and Annual Growth (Neuroimaging, In Vitro Diagnostics, Neuroinformatics)
5-2: FDA Approval and Insurance Reimbursement of Diagnostics
5-3: Neuroimaging Technology (CT, MRI, fMRI, PET, SPECT, EEG, MEG)
5-4: Alzheimer's Disease Neuroimaging Initiative
5-5: Neuroinformatics Data Storage
5-6: Paul Allen Brain Atlas Project and IBM Blue Brain Project

6-1: Total Venture Capital Investment, 1999-2011
6-2: Life Science Venture Capital Investment, 1999-2011
6-3: Neurotechnology Venture Capital Investment, 1999-2011
6-4: Neurotech as Percent of Life Science Venture Investment, 1999-2011
6-5: Top Five Neurotechnology Venture Capital Financings, 2001-2011
6-6: Top 110 Investors in Neurotech
6-7: Top 11 Neurotech Venture Capital Firms with Investments

7-1: Neurotechnology Initial Public Offerings US, 2004-Q2 2012
7-2: Neurotech Stock Universe Fundamentals 2012
7-3: Neurotech Index Performance Vs. S&P 500 and NASDAQ Biotech Index

8-1 Leading Neurotechnology Research Centers
8-2 Neurotech Research Centers and Affiliated Institutes, Funding, Recent Significant Investments, Reputation, Translation of Discoveries to Industry
8-3: UCSF
8-4: UCLA
8-5: Harvard University
8-6: Stanford University
8-7: MIT
8-8: Columbia University
8-9: Washington University
8-10: University College London
8-11: Karolinska Institute
8-12: RIKEN Brain Science Institute

9-1 NeuroInsights' Leading Neurotech Nexus Ratings
9-2 Conclusions and Policy Recommendations

10-1 Neuropharmaceutical Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-2 Neuropharmaceutical Companies Public Profiles (status, symbol, HQ, market cap revenues, description)
10-3 Neurodevice Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-4 Neurodevice Companies Public Profiles (status, symbol, HQ, market cap revenues, description)
10-5 Neurodiagnostic Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-6 Neurodiagnostic Companies Public Profiles (status, symbol, HQ, market cap revenues, description)

23andMe
454 Life Sciences
7TM Pharmaceuticals

A
AbaStar MDx
Abbey Pharmaceuticals
Abbott

Abiogen
Acadia Pharmaceuticals

Accera
AccSys Technology
Accuray
AcelRx
AC Immune
Acorda

Actelion
Active Biotech
Acucela
Acumen Pharmaceuticals
Acura
Adamas
Addex Pharmaceuticals

Adenios
Adenosine Therapeutics
Adeona
Aderis Pharmaceuticals
ADial
Adlyfe
Adolor
Advanced Bionics
Advanced Brain Monitoring
Advanced Brain Technologies
Advanced Cell Technology
Aeolus
Aestus Therapeutics
Affectis
Afferent Pharmaceuticals
AFFiRiS
Affymetrix
Afraxis
Agenebio
Alcon
Alder Biopharma
Aleva Neurotherapeutics
Alexion
Alexza Pharmaceuticals

AlgoRx Pharmaceuticals
Algos Therapeutics
AlgoStim
Alimera
Alinea
Alkermes
Allen Institute for Brain Science
Allergan
Allon Therapeutics
AllTranz Pharmaceuticals
Alnylam
Alpha Omega Engineering
Alpharma
ALS Biopharma
Alseres
Alsius
Alza
Alzhyme
Amarantus
Ambrose Pharmaceuticals
Ambrx
Ameritox
Amersham
Amgen
Amicus
Amkor
Amplimmune
Amsterdam Molecular
Anavex
Anesiva
AngioChem
ANM Adaptive
Annexon
Antisense Therapeutics
Anylam
Apitope
Apnex Medical
Aranthus Therapeutics
Archer Pharma
Archimedes
Arcion
Ardian
Arena Pharmaceuticals

Ariston
ArmaGen
Arteaus Therapeutics
Arteus
Artielle
ArunA
Asklepios
Aspreva
AssureRx
Astellas
Astraea Therapeutics
AstraZeneca

Astro-Med
AsuraGen
Athena Diagnostics
Athersys
AurimMed Pharma
Auris Medical
Autifony
Autonomic Technologies
Avanir
Avicena
Avid Radiopharmaceuticals
Avineuro
Avraham Pharmaceuticals
Axerion Therapeutics
AxoGen
Axon Neuroscience
Axxam
Azevan

B
Banyan Biomarkers
Barofold
BaroSense
Baxter
Bayer
Bayhill Therapeutics
Bedford Stem Cell Research Foundation
Beike
BeneChill
BHR Pharma
BIAL
Bioalvo
BioArctic
Bioasis
BioAxone
BioBehavioral Diagnostics
BioControl Systems
Biocortech
Biocrea
Biodesy
BioDirection
BioFocus
Biofrontera
Biogen Idec

BioLineRx
Biomarin
Bioness
Bionomics
BioRad
Biota
Biotie

Biovitrum
Blackrock Microsystems
Blue Marble Game Company
Boehringer Ingelheim
Boston Scientific

Bracco Diagnostics
BrainCells, Inc

BrainLAB
Brain Plasticity Insitute
Brain Resource
BrainScope
BrainsGate
BrainStorm Cell Therapeutics
Brainsway
Braintact, Ltd.
BrainTrain
BrainZ
Brane Discovery
Bristol Myers Squibb

Britannia
BTG International
Buck Institute for Age Research
BW Safari

C
Cadence
Cadwell Laboratories
California Stem Cell
Cambridge Cognition
Canbex
Capnia
Cara Therapeutics
Cardium Therapeutics
Carlsson Research
Catalyst
CCC Medical Devices
CDHI
Celentyx
Cell Cure Neurosciences
CellMed
Cell Therapeutics
Cellzome
Celtic
Celvive
CeNeRx
Centocor
Cerebral Vascular
Cerecor
Ceregene

Cerenaic
Cerephex
Cerimon
Cervel Neurotech
Chaperone Therapeutics
Chase Pharmaceuticals
CHDI Foundation
Checkpoint Surgical
Cheisi
Chelsea Therapeutics
Chestnut
Chiesi Farmaceutici
Chondrogene
Chugai
CIRTEC Medical
Civitas
Clarus Medical
Clera
Cleveland Clinic
Cleveland Medical Devices
CNS Response
CNS Vital Signs
CoAxia
Cochlear Ltd.
Codman
Cogmed
CogniFit
Cognition Therapeutics
Cognitive Drug Research
Cognitive Pharma
Cognosci
CogState
CoLucid
Combimatrix
CombinatoRx
CoMentis

Compellis
Compumedics
Concentric Medical
Concert Pharmaceuticals
Convergence Pharma
CoolSpine
Corcept Therapeutics
Cordis
Cortech
Cortex
Cortica Neurosciences
Covidien
CPS Innovations
CTI Molecular Imaging
Cubist
Curidium
CVRx
CyberLearning
Cyberonics
CyDex Pharma
Cynapsus
Cyrenaic Pharmaceuticals
Cytomedix
Cytos
Cytox

D
D-Pharm
Daiichi Sankyo
Dainippon
Dakim
Dara Bioscience
DarPharma
Dart Neuroscience
DaVinci Biosciences
Debiopharm
DeCODE Genetics
Depomed
DiaGenic
Dianippon
DNATraits
Domain Therapeutics
Durect
Durin Technologies
Dynogen

E
e-therapeutics
EBS Technologies
Edgemont Pharmaceuticals
Edge Therapeutics
EEG Spectrum
Eisai

Ekos
Elan

elbion
Elcelyx Therapeutics
Electrical Geodesics
ElectroCore
Elekta
Eli Lilly

Elixir
Ellipsis
ElMinda
Embera
Emisphere
EMKinetics
Emotiv Systems
EncephRx
Endo Pharmaceuticals
Endostim
eNeura
Enkam Pharmaceuticals
eNOS
Enpath
Ensemble Discovery
EnteroMedics
EnVivo Pharmaceuticals

Envoy Medical
Envoy Therapeutics
Eos Neuroscience
EpiCept
Epilepsy Therapy Project
EStimME
Ethicon
Euthymics Bioscience
Everest Medical
Evotec

ExonHit
EyeCyte
Eyegate

F
Fabre-Kramer
Fast Forward
FineTech Medical
FivePrime
Flowonix
FoldRx
Fonar
Forest

Fovea
Functional Neuromodulation

G
Galenea
GE

Gedeon Richter
Gelesis
GeneNews
Genentech
Genesis Medical Imaging
Genetix Pharmaceuticals
GeNeuro
Genmab
GenVec
Genzyme
Geron
GI Dynamics
Gladstone Institute
GlaxoSmithKline

Glenmark
Greatbatch
Guilford Pharmaceuticals
GW Pharmaceuticals

H
H. Lundbeck

Hamilton Pharmaceuticals
Heidelberg Engineering
Helicon Therapeutics
Heptares
Hermo Pharma
Hitachi Medical Systems
Horizon Pharma
Hospira
Hydra Biosciences

I
i3 Research
Icagen
ICVRx
Ikano Therapeutics
Imagine Neuro Solutions
Imagine Pharmaceuticals
ImaRx
Immune Response Biopharma
Impax
Impel Neuropharma
ImThera Medical
Incline Therapeutics
Inflazyme
Ingenium
Innate Therapeutics
InnerCool Therapies
InSound
Inspire Medical
Institute for the Study of Aging
Intec Pharma
Integra
Integragen
Intelect Medical
IntelGenx
Intelligent Medical Implants
International Stem Cell Corporation
Intra-Cellular Therapies
Intrapace
Invitrogen
InVivo Therapeutics
iPierian
Ipsen
Ironwood
iZumi Bio

J
Janssen

Jazz Pharmaceuticals

Jingxin
Johns Hopkins Brain Science Institute
Johnson & Johnson
172, 194, 196, 199, 205, 209

Jordan Neuroscience

K
Kai Pharmaceuticals
Kalypsys
Kappametrics
Karuna
Kempharm
KeyNeurotek
Kitalpha Med
Knopp Neuro
Kosei
Kowa
Krenitsky Pharmaceuticals
Kyalin Biosciences
Kyowa

L
LabCorp
LA MONT Medical
Lexicon
Lexicor Medical
Ligand
Lineagen
Link Medicine
Luitpold
Lumos Labs
Lundbeck

Lungpacer

M
M.J. Fox Foundation
M's Science
Maas Biolab
MacuCLEAR
Magstim
Map Pharmaceuticals
Marco Polo
Marina Biotech
Marinus
Masimo
MED-EL
Meda
Medasys
MedAvante
Medesis
MedGenesis
MediciNova
Medistem
Meditor
MediVance
Medivation
Medra
Medtrode
Medtronic

Meiji Seika
Merck

Merck Serono
Merlin MD
Merz
Mesoblast
Metabolon
MetaCure
Metaphore Pharmaceuticals
Michael J. Fox Foundation
MicroTransponder
Microvention Terumo
Millipore
Mind-NRG
MindCare
MindFrame
Mindguard
Mind Research Network
Mission Pharmacal
Mithridion
Mitsubishi Pharma
Mnemosyne Pharma
Mochida
Moeller Medical
Molecular Neuroimaging
Monteris
Morphosys
MRC Systems
Myomo
Myriad
Myriad RBM

N
NanoNerve
Nano Retina
Nanovector
Natus Medical
Naurex
Nautilus Neuroscience
Navidea Biopharmaceuticals
Navigenics
NDI Medical
Nektar
Neopraxis
NeoStim
NeoVista
Nervomatrix
Neural Signals
NeuralStem
Neuraltus
Neuralynx
NeurAxon
Neurelec
Neurelis
Neuren
Neurex
Neurim
Neurimmune Therapeutics
NeuroActive
Neuroadjuvants
Neurobiological Technologies
Neuro Biomed
Neurocare
Neurocrine
Neurodan
NeuroDerm
NeuroDiscovery
NeuroDx Development
Neurodyne
Neurofit
NeuroFluidics
NeuroFocus
Neurogen
NeuroGeneration
NeuroGenetic Pharmaceuticals
Neurogenetics
NeuroGenomeX
NeurogesX
NeuroHealing
Neuro Hi-Tech Pharmaceuticals
NeuroKin
Neuro Kinetics
NeuroKos
NeuroLink Medical
Neurolixis
NeuroLogic
NeuroLogica
Neurologics
Neurologix
Neurolutions
Neuromed
NeuroMetrix
NeuroMolecular Pharmaceuticals
NeuroNascent
Neuronax
Neuronetics
Neuronetrix
NeuroNexus
Neuronix
NeuroNova
NeurOp
NeuroPace

NeuroPhage
NeuroPhysics
Neuropore
NeuroPore Therapies
NeuroProfile
Neuroptix
NeuroRepair
Neuros
Neuroscan
NeuroScience Pharmaceuticals
NeuroSearch

NeuroSigma
NeuroSky
Neuros Medical
NeuroSync
Neurotar
Neurotech SA
Neurotez
NeuroTherapeutics Pharma
NeuroTrax
NeuroTrek
Neurotrek
Neurotune
NeuroVasx
NeuroVigil
NeuroVista
NeuroVive
NeuroWave Systems
Nevro
Newron

Nexstim
NextWave Pharmaceuticals
NFocus
Nicolet Biomedical
Nihon Kohden
NimbleGen
Nippon Shinyaku
Nocacea
NoNo
Nordocs
Norgine
Noscira
Novadel
Novartis

Noven
NovoNordisk
Novosis
NPS Pharmaceuticals
NsGene
Nuon Therapeutics
NuPathe
Nuron
Nymox

O
Obalon Therapeutics
Obecure
Odyssey
Olympus
Omneuron
Ono Pharmaceuticals
Opexa
Ophthotech
OPKO
Optherion
Opthotech
Optima Neuroscience
OptiNose
Optinose
Optobionics
OptumHealth
Ora Bio
Oraya Therapeutics
Orexeo
Orexigen
Organon
Orion
Orphan Medical
Ortho-McNeil
Oryx Pharmaceuticals
OSI Pharmaceuticals
Othera
OtoKinetics
Otonomy
Otsuka
Ovation Pharmaceuticals
Oxford Biomedica
Oxford Instruments
Oxigene

P
P2D Bioscience
Pacira
Pain Therapeutics
Paion
Paladin
Palatin
Paloma
Palyon
PanOptica
Pathogenics
Pearson
Pediatric Bioscience
Pentech
Penumbra Inc.
Penwest
Peptimmune
Pfizer

Phagenesis
Pharmacia
PharmaNess
PharmaNeuroBoost
PharmaPass
PharmatrophiX
Pharmaxon
PharmEste
Pharmos
Pharnext
Phase 2 Discovery
Pherin
Philips

PhotoThera
PhysioSonics
Phytopharm
Picker
Pierre Fabre
Plexon
Posit
Positron Corporation
Pozen
Prana Biotech
Prestwick Pharmaceuticals
Prexa Pharmaceuticals
Prexton Therapeutics
Pritzker Neuropsychiatric Disorders Research Consortium

Prize4Life
Probiodrug
ProEthic
Progenics
Proneuron
Prosensa
Prospex Medical
Protalix
Proteostasis
Proteosys
Proteotech
Provid
Proximagen Neuroscience
pSividia
Psyadon
Psychogenics
Psylin
Psynova
Purdue

Q
QiG Group
QR Pharma
QRxPharma
Q Therapeutics
Quark Pharmaceuticals
Quest
Questcor
Quickcool

R
Radiant Medical
Ranbaxy
Raptor Pharma
RaQualia
Reata Pharmaceuticals
Receptos
Reckitt Benckiser
RedHill Biopharma
Regeneron
Relievant Medsystems
Remedy Pharma
ReMYND
ReNeuron
Renovis
Repligen
Reset Therapeutics
Retina Implant
Reverse Medical
Rexahn
Rhenovia
RhinoCyte
Rhythm Pharmaceuticals
Ridge Diagnostics
Rinat
Roche

S
Sage Therapeutics
SanBio
Sanofi

Sanofi-aventis

Santhera
SantoSolve
Sapiens Brain Steering Stimulation
Sarentis Therapeutics
Satiety
Satori Pharmaceuticals
Schering-Plough

Schwarz
Scientific Brain Training
Scientific Learning
Second Sight
Seimens
Selecta
Senexis
SeneXta
Senomyx
Sensory Medical
SeqWright
Servier
SetPoint Medical
Shimadzu Medical Systems
Shionogi
Shire

Siemens

Siena Biotech
Sigmedics
Signum Biosciences
Silere Medical
Simprota
Sinapis Pharma
Sirion
SK Biopharmaceuticals

SleepMed
SmartBrain Technologies
Solace Pharmaceuticals
Solstice
Solvay
Somanetics
Somaxon

Somerset Pharmaceuticals
Somnus
Sonexa
Sonova
Sosei
Sound Pharmaceuticals
Spencer Technologies
Spherics
Spinal Cord Therapeutics
Spinal Modulation
SPR Therapeutics
St. Croix Medical
St. Jude Medical

StemCells, Inc.
Stem Cell Sciences
StemCell Technologies
Stem Cell Therapeutics

Stemedica
Stereotaxis
StimWave
St Jude Medical
Stryker
STX Medical
Summit
Sunovion
Supernus
SureGene
Suven
Sygnis
SynapDx
Synapse Biomedical
Synaptic Pharmaceutical
Synergia Pharma
Syngis
Syntaxin
Syntropharma

T
Taisho
Takeda

Tal Medical
Tanabe
Targacept

Targegen
Targeted Genetics
TauRx Therapeutics
TauTaTis
TCA Cellular Therapy
TeachTown
TeraRecon
Teva

Theracos
TheraNova
TheraQuest
Thiakis
Tikvah
Titan Pharmaceuticals
toBBB
TONIX Pharma
Toshiba
Touch Bionics
Transcept Pharma
Transcription Diagnostics
Transition Therapeutics
Transneuronix
TransOral
TransTech
Tranzyme
Trevena
Treventis
Trophos
Tucker-Davis

U
UCB

Unique Logic and Technology
Upsher-Smith
US Worldmeds

V
Valeant

Validus
Vanda

Vantage Mobile Services
Varian
Vasopharm
Vastox
Vela Pharmaceuticals
Velocimed
Vernalis
Vertex
Victhom Human Bionics
Victory
Visioncare
VisionCare Ophthalmic
Vistagen
Visualase
Vitae
Vivity Labs
Vivus
Vycor
Vyteris

W
Wex Pharmaceuticals
Wicab
Wild Divine
Winston Pharma

X
Xanodyne
Xenome
Xenon
XenoPort
Xenova
Xention
Xsira

Y
Yuma Therapeutics

Z
Zafgen
Zalicus
Zambon
Zenobia Therapeutics
Zinfandel Pharmaceuticals
Zogenix
Zoll Medical